James Chan, MD
Otolaryngology/Facial Plastic Surgery · Clackamas, ORNPI 1972543106
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,399 of the $4,323 with a category attached, or 78.6%. 14 manufacturers reported payments, led by Aerin Medical Inc. at 38.6% of the total. Reporting peaked in 2024 at $1,878 and has fallen 92.8% since, to $135 in 2025.
Across 78 payments — averaging $55.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- Merz North America, Inc.$1K
- Intersect ENT, Inc.$603
- AbbVie$484
- Jazz Pharmaceuticals Inc.$96
- Galderma Laboratories, L.p.$71
- plus $250 from 8 others
What the payments were for
- Consulting fees$1002%
- Travel & lodging$82419%
- Food & beverage$3,39979%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 16 | $1,667 |
| Merz North America, Inc. | 17 | $1,151 |
| Intersect ENT, Inc. | 7 | $603 |
| AbbVie | 22 | $484 |
| Jazz Pharmaceuticals Inc. | 3 | $96 |
| Galderma Laboratories, L.p. | 3 | $71 |
| KARL Storz Endoscopy-america | 1 | $49 |
| Medtronic | 1 | $49 |
| Sanofi | 2 | $40 |
| Advanced Bionics, LLC | 1 | $38 |
| Stryker | 2 | $24 |
| Optinose US, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Arrinex, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,109
- PROPEL$235
- SINUVA$149
- RHINAER STYLUS$133
- XEOMIN$105
How this compares
Too few otolaryngology/facial plastic surgery providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $209 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $182 |
| Ondansetron OdtOndansetron | 20 | $163 |
| Methylprednisolone | 13 | $78 |
| Acyclovir | 14 | $42 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Clackamas
- Robert RobertsClackamas$5K
- Mark RobertsonAlbany$7K
- Zipei FengPortland$2K
- Deniz GerecciPortland$1K
- Kayva CrawfordPortland$1K
- Natalie KraneBeaverton$616
- Alia MoweryPortland$286
- Richard HuffakerGrants Pass$182
- Kenneth McCarleyEugene$148
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.